Role of β4∗ Nicotinic Acetylcholine Receptors in the Habenulo-Interpeduncular Pathway in Nicotine Reinforcement in Mice

Neuropsychopharmacology

Volumn 41, Issue 7, 2016, Pages 1790-1802

  Harrington, Lauriane ^a,b   Viñals, Xavier ^c   Herrera Solís, Andrea ^c   Flores, Africa ^c   Morel, Carole ^d   Tolu, Stefania ^d   Faure, Philippe ^d   Maldonado, Rafael ^c   Maskos, Uwe ^a,b   Robledo, Patricia ^c,e  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8246   (France)

^e HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; DOPAMINE; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA4; UNCLASSIFIED DRUG; CHRNB4 PROTEIN, MOUSE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; NERVE PROTEIN; NICOTINIC AGENT; PHOSPHOGLYCERATE KINASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INFUSION; ELECTROPHYSIOLOGICAL PROCEDURES; ELECTROPHYSIOLOGY; FEMALE; HABENULA; INSTRUMENTAL CONDITIONING; INTERPEDUNCULAR NUCLEUS; MALE; MICRODIALYSIS; MOUSE; NERVE CELL; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINFORCEMENT; TRANSGENIC MOUSE; VENTRAL TEGMENTUM; ACTION POTENTIAL; ANIMAL; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSDUCTION; GENETICS; METABOLISM; PHYSIOLOGY;

ACTION POTENTIALS; ANIMALS; CONDITIONING, OPERANT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GREEN FLUORESCENT PROTEINS; HABENULA; INTERPEDUNCULAR NUCLEUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRODIALYSIS; NERVE TISSUE PROTEINS; NICOTINE; NICOTINIC AGONISTS; PHOSPHOGLYCERATE KINASE; RECEPTORS, NICOTINIC; REINFORCEMENT (PSYCHOLOGY); TRANSDUCTION, GENETIC;

EID: 84953245372     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.346     Document Type: Article

References (47)

1. Antolin-Fontes B, Ables JL, Görlich A, Ibañez-Tallon I (2014). The habenulo-interpeduncular pathway in nicotine aversion and withdrawal. Neuropharmacology 96: 213-222.
2. Beiranvand F, Zlabinger C, Orr-Urtreger A, Ristl R, Huck S, Scholze P (2014). Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenulointerpeduncular complex. Br J Pharmacol 171: 1-41.
3. Berrendero F, Plaza-Zabala A, Galeote L, Flores Á, Bura SA, Kieffer BL (2012). Influence of δ-opioid receptors in the behavioral effects of nicotine. Neuropsychopharmacology 37: 2332-2344.
4. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X et al (2008). Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
5. Dao DQ, Perez EE, Teng Y, Ja Dani, De Biasi M (2014). Nicotine enhances excitability of medial habenular neurons via facilitation of neurokinin signaling. J Neurosci 34: 4273-4284.
6. Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C et al (2004). Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47(Suppl 1): 227-241.
7. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA (1997). Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17: 5747-5759.
8. Fields HL, Hjelmstad GO, Margolis EB, Nicola SM (2007). Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu Rev Neurosci 30: 289-316.
9. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ (2011). Habenular a5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601.
10. Fowler CD, Kenny PJ (2014). Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability. Neuropharmacology 76.
11. Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S et al (2011). Aversion to nicotine is regulated by the balanced activity of ß4 and a5 nicotinic receptor subunits in the medial habenula. Neuron 70: 522-535.
12. Gallego X, Cox RJ, Laughlin JR, Stitzel JA, Ehringer MA (2013). Alternative CHRNB4 3'-UTRs mediate the allelic effects of SNP rs1948 on gene expression. PloS One 8: e63699.
13. Geisler S, Zahm DS (2005). Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions. J Comp Neurol 490: 270-294.
14. Glick SD, Sell EM, McCallum SE, Maisonneuve IM (2011). Brain regions mediating a3ß4 nicotinic antagonist effects of 18-MC on nicotine self-administration. Eur J Pharmacol 669: 71-75.
15. Görlich A, Antolin-Fontes B, Ables JL, Frahm S, Slimak MA, Dougherty JD et al (2013). Reexposure to nicotine during withdrawal increases the pacemaking activity of cholinergic habenular neurons. Proc Natl Acad Sci USA 110: 17077-17082.
16. Grady SR, Moretti M, Zoli M, Marks MJ, Zanardi A, Pucci L et al (2009). Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4∗ and alpha3beta3beta4∗ subtypes mediate acetylcholine release. J Neurosci 29: 2272-2282.
17. Groenewegen HJ, Ahlenius S, Haber SN, Kowall NW, Nauta WJ (1986). Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat. J Comp Neurol 249: 65-102.
18. Haller G, Druley T, Vallania FL, Mitra RD, Li P, Akk G et al (2012). Rare missense variants in CHRNB4 are associated with reduced risk of nicotine dependence. Hum Mol Genet 21: 647-655.
19. Hansen SB, Sulzenbacher G, Huxford T, Marchot P, Taylor P, Bourne Y (2005). Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J 24: 3635-3646.
20. Hartmann-Boyce J, Stead LF, Cahill K, Lancaster T (2013). Efficacy of interventions to combat tobacco addiction: cochrane update of 2012 reviews. Addiction 108: 1711-1721.
21. Hsu Y-WA, Tempest L, Quina La, Wei AD, Zeng H, Turner EE (2013). Medial habenula output circuit mediated by 5 nicotinic receptor-expressing GABAergic neurons in the interpeduncular nucleus. J Neurosci 33: 18022-18035.
22. Hsu Y-WA, Wang SD, Wang S, Morton G, Zariwala HA, de la Iglesia HO et al (2014). Role of the dorsal medial habenula in the regulation of voluntary activity, motor function, hedonic state, and primary reinforcement. J Neurosci 34: 11366-11384.
23. Jackson KJ, Sanjakdar SS, Muldoon PP, McIntosh JM, Damaj MI (2013). The a3ß4∗ nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the a5 subunit in the mouse. Neuropharmacology 70: 228-235.
24. Kobayashi Y, Sano Y, Vannoni E, Goto H, Suzuki H, Oba A et al (2013). Genetic dissection of medial habenula-interpeduncular nucleus pathway function in mice. Front Behav Neurosci 7: 17.
25. Maskos U, Molles BE, Pons S, Besson M, Guiard BP, Guilloux J-P et al (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
26. Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP (2008). Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health 98: 317-322.
27. Morel C, Fattore L, Pons S, Ya Hay, Marti F, Lambolez B et al (2014). Nicotine consumption is regulated by a human polymorphism in dopamine neurons. Mol Psychiatry 19: 930-936.
28. McCallum SE, Cowe MA, Lewis SW, Glick SD (2012). a3b4 nicotinic acetylcholine receptors in the medial habenula modulate the mesolimbic dopaminergic response to acute nicotine in vivo. Neuropsychopharmacology 63: 434-440.
29. Orejarena MJ, Herrera-Solís A, Pons S, Maskos U, Maldonado R, Robledo P (2012). Selective re-expression of ß2 nicotinic acetylcholine receptor subunits in the ventral tegmental area of the mouse restores intravenous nicotine self-administration. Neuropharmacology 63: 235-241.
30. Paxinos G, Franklin K (2004). The Mouse Brain in Stereotaxic Coordinates. Elseiver Academic: San Diego.
31. Ren J, Qin C, Hu F, Tan J, Qiu L, Zhao S et al (2011). Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 69: 445-452.
32. Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF et al (2009). The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res 69: 6848-6856.
33. Salas R, Pieri F, De Biasi M (2004). Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci 24: 10035-10039.
34. Salas R, Pieri F, Fung B, Dani Ja, De Biasi M (2003). Altered anxiety-related responses in mutant mice lacking the beta4 subunit of the nicotinic receptor. J Neurosci 23: 6255-6263.
35. Salas R, Sturm R, Boulter J, De Biasi M (2009). Nicotinic receptors in the habenulo-interpeduncular system are necessary for nicotine withdrawal in mice. J Neurosci 29: 3014-3018.
36. Sanchis-Segura C, Spanagel R (2006). Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11: 2-38.
37. Schlaepfer IR, Hoft NR, Collins AC, Corley RP, Hewitt JK, Hopfer CJ et al (2008). The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63: 1039-1046.
38. Slimak MA, Ables JL, Frahm S, Antolin-Fontes B, Santos-Torres J, Moretti M et al (2014). Habenular expression of rare missense variants of the ß4 nicotinic receptor subunit alters nicotine consumption. Front Hum Neurosci 8: 12.
39. Suto N, Wise RA (2011). Satiating effects of cocaine are controlled by dopamine actions in the nucleus accumbens core. J Neurosci 31: 17917-17922.
40. Tolu S, Eddine R, Marti F, David V, Graupner M, Pons S et al (2013). Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol Psychiatry 18: 382-393.
41. Tuesta LM, Fowler CD, Kenny PJ (2011). Recent advances in understanding nicotinic receptor signaling mechanisms that regulate drug self-administration behavior. Biochem Pharmacol 82: 984-995.
42. Ungless MA, Grace AA (2012). Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. Trends Neurosci 35: 422-430.
43. Walters CL, Brown S, Changeux JP, Martin B, Damaj MI (2006). The ß2 but not a7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology 184: 339-344.
44. World Health Organization (2013). WHO Report on the Global Tobacco Epidemic, vol 2015. World Health Organization: Geneva, Switzerland.
45. Xu W, Orr-Urtreger A, Nigro F, Gelber S, Sutcliffe CB, Armstrong D et al (1999). Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19: 9298-9305.
46. Yamaguchi T, Danjo T, Pastan I, Hikida T, Nakanishi S (2013). Distinct roles of segregated transmission of the septo-habenular pathway in anxiety and fear. Neuron 78: 537-544.
47. Zhao-Shea R, Liu L, Pang X, Gardner PD, Tapper AR (2013). Activation of GABAergic neurons in the interpeduncular nucleus triggers physical nicotine withdrawal symptoms. Curr Biol 23: 2327-2335.